In vitro activity of bay 12-8039, a new 8-methoxyquinolone

Chemotherapy

Volumn 42, Issue 6, 1996, Pages 410-425

  Dalhoff, A ^a   Petersen, U ^a   Endermann, R ^a  

^a BAYER AG   (Germany)

Author keywords

8 Methoxyquinolone; Anaerobes; BAY 12 8039; Gram negatives; Gram positives; In vitro; Killing kinetics; MICs; Mutation frequency

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; CEFUROXIME; CIPROFLOXACIN; CLARITHROMYCIN; CLAVULANIC ACID; METRONIDAZOLE; MOXIFLOXACIN; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPARFLOXACIN; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; BACTEROIDES FRAGILIS; CLOSTRIDIUM; ESCHERICHIA COLI; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES;

EID: 0029842831     PISSN: 00093157     EISSN: 14219794     Source Type: Journal    
DOI: 10.1159/000239474     Document Type: Article

References (17)

1. Eliopoulos GM, Eliopoulos CT: Activity in vitro of the quinolones; in Hooper DC, Wolfson JS: Quinolone Amtimicrobial Agents, ed 2. Washington. American Society for Microbiology, 1993. pp 161-193.
2. Thys JP, Jacobs F, Bvl B: Role of quinolones in the treatment of bronchopulmonary infections, particularly pneumococcal and community-acquired pneumonia. Eur J Clin Microbiol Infect Dis 1991:10:304-315.
3. Pankey GA, Kalish GH, Wallach M: Ciprofloxacin in lower respiratory tract and skin/skin structure infections: A phase IV surveillance study. Infect Med 1990;7:41-48.
4. Pankev GA: Multicenter, phase IV evaluation of intravenous ciprofloxacin as initial therapy in patients with lower respiratory tract, urinary tract, and skin/skin structure infections. Clin Ther 1995;17:353-365.
5. Fink MP, Snydman DR, Nieder-man MS, et al: Treatment of severe pneumonia in hospitalized patients: Results of a multiecntcr randomized. double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin. Antimicrob Agents Chemother 1994:38: 547-557.
6. Ball AP, Tillotson GS: Lower respiratory tract infection therapy - The role of ciprofloxacin. J lnt Med Res 1995;23:315-327.
7. Jolley A, Adrews JM, Brcuwald N, Wise R: The in vitro activity of a new highly active quinolone. DU-6859a. J Antimicrob Chemother 1993:32:757-763.
8. Child J, Adrcs J, Boswell F, Breu-wald N, Wise R: The in vitro activity of CP99.219. a new caph-thyridone antimicrobial agent: A comparison with fluoroquinolone agents. J Antimicrob Chemother 1995:35:869-876.
9. Eliopoulos GM, Klimm K, Eliopou-los GT, Ferraro MJ, Moellering RC: In vitro activity of CP 99.219 a new lluoroquinolonc. against clinical isolates of gram positive bacteria. Antimicrob Agents Chemother 1993: 37:366-370.
10. Neu H, Chin N-X: In vitro activity of the new fluoroquinolone CP-99.219. Antimicrob Agents Chemother 1994,38:2615-2622.
11. Dalholt A: Activities of ciprofloxacin and sparfloxacin against 5 pneumoniae (abstract 34). 5th Int Svmp New Quinolones, Singapore. 1994.
12. Hyatt JM, Nix DH, Stratton CW, Schontag JJ: In vitro pharmacodynamics of piperacillin, piperacillin-lazobactam ar.d ciprofloxacin alone and in combination against Staphylococcus aureus, Klebsiella pneumoniae. Enterobacter cloacae, and Pseudomonas aeruginosa. Antimi-crob Agents Chemother 1995:39: 1711-1716.
13. Craig WA, Ebert SC: Killing and regrowth of bacteria in vitro: A review. Scand J Infect Dis 1991: 74(suppl):63-70.
14. Rüstige C, Wiedemann B: Pharmacodynamic differences of quino-lones towards bacteria with identical MICs (abstract 651). 17th Int Congr Chemothcr. Berlin. 1991.
15. Dalhoft A, Matutat S, Ullmann U: Effect of quinolones against slowly growing bacteria. Chemotherapy 1995;41:92-99.
16. Piddock IJV, Jin YF: Selection of quinolone-resistant mutants of Haemophilus influenzae and Streptococcus pneumoniae. J Antimicrob Che-mother 1992:30:109-110.
17. Thomson KS. Sanders CC: Dissociated resistance among fluoroquinolones. Antimicrob Agents Che-mother 1994:38:2095-2100.